New findings may lead to improved treatments for chemotherapy-resistant ovarian cancer

CD55 protein localizes in the nucleus of human ovarian cancer cells. Credit: Molecular Cancer (2024). DOI: 10.1186/s12943-024-02028-5 Cleveland Clinic researchers have discovered a new location for a protein that helps ovarian cancer cells resist chemotherapy treatments and that fosters aggressive cancer stem cell growth. These findings, published today in Molecular Cancer, may become the basis of a new approach to treat chemotherapy-resistant ovarian cancer that targets the protein CD55. Currently, the CD55 protein is difficult to target because of its protective role in the immune system and its location on Read More

Related posts:

  1. Destroying cancer-causing RNA could lead to bespoke treatments, say scientists
  2. Scientists developing at-home swab tests for endometrial, ovarian cancer
  3. Researchers find differences in ovarian cancer risk factors by racial and ethnic groups
  4. Study reveals novel immune-based biomarker helps detect ovarian cancer years before conventional diagnosis
  5. Stem cell-derived therapy shows promise against treatment-resistant liver cancer
  6. Reversing chemotherapy resistance in pancreatic cancer
  7. Crohn’s discovery could lead to better treatments for devastating condition
  8. Chemotherapy could disrupt gut microbiome in patients with breast cancer

Leave a Reply

Your email address will not be published. Required fields are marked *